Translation of "Joint infection" in German

A common cause of revisions is septic loosening due to a periprosthetic joint infection.

The MAH also listed a number of published studies and discussed other indications, such as skin and soft tissue infections (SSTI), bone and joint infections, abdominal infection, pelvic inflammatory disease, UTI and dental infections.

Ciloxan is an antibiotic-fluoroquinolone, is particularly effective for urinary tract infections, gonoreb, vospalenib lung infections of skin and soft tissue, bone and joint infections, barley, infection of the blood.

The cause can be abnormal bone or joint development, instability of the surrounding ligaments and tendons, damage or injury to the joint, an infection, or injury caused by the immune system.

A patient with chronic fatigue, susceptibility to infection, joint pain, and a positive blood test for borreliosis is treated initially but unsuccessfully with Silicea.

The complications possible with arthroscopy such as joint infection, blood vessel and nerve injuries are extremely rare (statistically under 1 %).

A periprosthetic infection (PPI, also known as a prosthetic joint infection) generally manifests as persistent or increasing joint pain and early prosthesis loosening.

If an infection is found in any other area of the body system, especially if it is found to be the source of the joint disease, treating the primary infection will as important as treating the joint infection.

Dr Carlo Luca Romanò, professor at the University of Milan and President of the European Bone and Joint Infection Society, is currently finalising a long-term project together with Dr Javad Parvizi, President of the Musculoskeletal Infection Society in the US.

Which antibiotic will work best for your dog will depend on the results of the culture and sensitivity testing, both of which will tell your veterinarian about the microorganism involved in the joint infection.

We achieve this by providing solutions for the fixation of joint implants, driving infection management and by pioneering regenerative treatments for bone, cartilage and soft tissue.

The above-mentioned complications and risks of blood transfusions, and especially that of postoperative prosthetic joint infection, can lead to significantly prolonged hospital stays and considerable costs (6 –8).

The risk of joint infection (bacterial inflammation) is low when the preparation is applied under sterile conditions.How often do we administer the injections?

In addition to radical surgical excision of the infected and necrotic tissue, the treatment of a prosthetic joint infection includes the systemic and local administration of antibiotics, ideally with combination preparations.

Joint or bursa infections must meet at least one of the following criteria:

This occurs when the staph bacteria reach a joint and infect it.

Antibiotics are prescribed in case of infected joints leading to arthralgia.

Besides, increasingly problematic gram-negative bacteria also are significant as causes of joint-associated infections.

Periprosthetic joint infections are a serious complication in arthroplasty and present a considerable therapeutic challenge.

The most commonly infected joints are the knees, but any joint is a possible location of staph infection.

The most common causes of arthritis include inflammation in the joint or joints, age and infection.

In studies, the most common side effects with Sprycel (seen in more than 1 patient in 10) were headache, pleural effusion (fluid around the lungs), dyspnoea (shortness of breath), cough, diarrhoea, nausea (feeling sick), vomiting, abdominal (tummy) pain, skin rash, musculoskeletal pain (pain in the joints and muscles), infection, haemorrhage (bleeding), superficial oedema (swelling), fatigue (tiredness), pyrexia (fever), neutropenia (low white blood cell counts), thrombocytopenia (low blood platelet counts) and anaemia (low red blood cell counts).

If you have a sudden occurrence or recent history of bone or joint infections, your MACI treatment should be temporarily delayed until your doctor considers that you have recovered.

In particular, four divergent indications (i.e., gynaecological infections, septicaemia, bone and joint infections, and endocarditis) and the use in paediatric patients less than 3 years of age were discussed.

The CHMP also assessed the limited data from literature sources and concluded that the claimed broad indication in the treatment of bone and joint infections could not be supported.

The CHMP noted the proposed indication “bone and joint infections” but considered the data submitted to be insufficient.

Therefore, in view of the available data and the fact that ceftriaxone has been approved by the majority of member states for bone and joint infections, the CHMP agreed with harmonised indication for: infections of bones and joints.

The CHMP generally agreed with the MAH conclusion, but further discussed the indications in LRTIs, URTIs, UTIs, gynaecological infections, SSTIs, bone and joint infections and the prophylaxis of surgical infections and agreed and adopted the following harmonised wording for inclusion in the harmonised SPCs:

As agreed by the CHMP, the indication for the treatment of bone and joint infections has been maintained without specifically mentioning osteomyelitis, septic arthritis and prosthetic infections.

The infections observed consisted primarily of bacterial events such as cellulitis, pneumonia, and bone and joint infections.

From the data presented, ciprofloxacin prescriptions in “ bone and joint infections” were supported by several clinical studies and an extensive use in clinical practice.

Today, quinolones and fluoroquinolones are used for over 120 indications in the EU, including different types of urinary tract, respiratory, genital, gastrointestinal tract, skin, bone, and joint infections.

Patients with local inflammations or acute as well as recent bone or joint infections should be temporarily deferred until the recovery from the infection is documented.